Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $17.2 million.

  • Biofrontera's Total Non-Current Liabilities rose 5075.1% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 5075.1%. This contributed to the annual value of $16.4 million for FY2024, which is 1326.54% down from last year.
  • Latest data reveals that Biofrontera reported Total Non-Current Liabilities of $17.2 million as of Q3 2025, which was up 5075.1% from $24.3 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Total Non-Current Liabilities registered a high of $29.0 million during Q4 2021, and its lowest value of $9.7 million during Q2 2024.
  • Over the past 5 years, Biofrontera's median Total Non-Current Liabilities value was $21.1 million (recorded in 2023), while the average stood at $20.4 million.
  • As far as peak fluctuations go, Biofrontera's Total Non-Current Liabilities plummeted by 5125.24% in 2024, and later soared by 14904.54% in 2025.
  • Biofrontera's Total Non-Current Liabilities (Quarter) stood at $29.0 million in 2021, then fell by 16.76% to $24.2 million in 2022, then decreased by 21.66% to $18.9 million in 2023, then dropped by 13.27% to $16.4 million in 2024, then increased by 4.54% to $17.2 million in 2025.
  • Its Total Non-Current Liabilities stands at $17.2 million for Q3 2025, versus $24.3 million for Q2 2025 and $15.4 million for Q1 2025.